Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: FF; Drug: UMEC; Drug: VI
Sponsor: GlaxoSmithKline
Not yet recruiting – verified May 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
A Study to Assess the Bronchodilator Effect of a Single Dose of Fluticasone Furoate (FF)/ Vilanterol (VI) 100/25 Micrograms (Mcg) Combination When Administered in Adult Patients With Asthma
Condition: Asthma
Interventions: Drug: FF/VI 100/25 mcg; Drug: Placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Not yet recruiting – verified April 2013
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Efficacy in asthma of once-daily treatment with fluticasone furoate: a … – 7thSpace Interactive (press release)
|
Efficacy in asthma of once-daily treatment with fluticasone furoate: a …
7thSpace Interactive (press release) Methods: Asthma patients maintained on ICS for [greater than or equal to]3 months with baseline morning forced expiratory volume in one second (FEV1) 50-80% of predicted normal value and FEV1 reversibility of [greater than or equal to]12% and [greater … |
View full post on asthma – Google News
Efficacy and Safety of Mometasone Furoate for Persistent Asthma Previously Treated With Low-Dose Inhaled Glucocorticosteroids (ICS) (Study P06115)
Condition: Asthma
Interventions: Drug: SCH 32088 mometasone furoate (MF) metered-dose inhaler; Drug: Placebo metered-dose inhaler BID
Sponsor: Schering-Plough
Not yet recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Evaluating the Efficacy and Safety of Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Adults and Adolescents
Condition: Asthma
Interventions: Drug: Fluticasone propionate inhalation powder; Drug: Fluticasone furoate inhalation powder; Drug: Placebo inhalation powder
Sponsor: GlaxoSmithKline
Recruiting – verified October 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Dose Proportionality Study: Blood Levels of Fluticasone Furoate (FF) and Vilanterol (VI) Following Different Doses of FF/VI Via an Inhaler
Condition: Asthma
Interventions: Drug: Fluticasone furoate 50 mcg (4 inhalations); Drug: Fluticasone furoate 100 mcg (4 inhalations); Drug: Fluticasone furoate 200 mcg (4 inhalations); Drug: Vilanterol 25 mcg (4 inhalations)
Sponsor: GlaxoSmithKline
Not yet recruiting – verified October 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
QTc Study With Flucticasone Furoate & GW642444
Conditions: Asthma; Chronic Obstructive Pulmonary Disease
Interventions: Drug: Fluticasone furoate (200 mcg)/GW642444 (25mcg) combination; Drug: Fluticasone furoate (400 mcg)/GW642444 (50mcg) combination; Drug: Placebo Inhaler; Drug: Moxifloxacin 400mg; Drug: Moxifloxacin placebo
Sponsor: GlaxoSmithKline
Recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Acute Effect of Mometasone Furoate DPI on Beta-adrenergic Airway and Airway Vascular Relaxation in Moderately Severe Asthma
Condition: Asthma
Interventions: Drug: Mometasone furoate; Drug: placebo
Sponsors: University of Miami; Schering-Plough
Not yet recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Once-Daily Fluticasone Furoate Provides Effective Control in Symptomatic … – DG News
 UK News Reporter |
Once-Daily Fluticasone Furoate Provides Effective Control in Symptomatic …
DG News BARCELONA — September 20, 2010 — Once-daily fluticasone furoate is well tolerated and provides effective asthma control in symptomatic … New Hope For Asthma Sufferers New Combination for Asthma Shows Encouraging Results in Delivering Efficacy … |
View full post on asthma – Google News